Attachment of Staphylococcus aureus is required for activation of nuclear factor kappa B in human osteoblasts.
Nuclear factor kappa B (NF-κB) plays a prominent role in the pathogenesis of infectious diseases. Staphylococcus aureus (S. aureus), which can attach to and invade human osteoblasts, is the most common causative agent of osteomyelitis. To determine whether S. aureus can activate NF-κB in human osteoblasts and explore the possible factors of activation in response to infection, we used flow cytometry, enzyme-linked immunosorbent assay, immunoblots, and electrophoretic mobility shift assays to quantify the invasion of bacteria, to measure the interleukin-6 (IL-6) of culture supernatants, and to investigate the IκBα degradation and NF-κB activation in human osteoblasts. Moreover, we explored the possible factors responsible for the activation of NF-κB by preventing S. aureus from physically touching human osteoblasts or inhibiting the invasion of S. aureus into human osteoblasts under co-culture conditions, by incubating proteinase K-treated or ultraviolet-killed S. aureus with human osteoblasts and by treating human osteoblasts with peptidoglycan (PGN) or lipoteichoic acid (LTA). We found that S. aureus induced the IκBα degradation and NF-κB activation, which could regulate IL-6 secretion in the culture supernatants of human osteoblasts in response to infection. In addition, the maximal IκBα degradation and NF-κB activation in human osteoblasts occurred prior to the maximal invasion of S. aureus. It was the attachment not invasion or the secreted soluble factor(s), PGN, LTA of S. aureus, that could induce the IκBα degradation and NF-κB activation in human osteoblasts. These results indicated that S. aureus can activate NF-κB in human osteoblasts and that the attachment of S. aureus is required for this activation in response to infection.
Department of Orthopaedics, The Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, China.
Rende
R
Ning
Xianlong
X
Zhang
Xiaokui
X
Guo
Qingtian
Q
Li
D001422:Bacterial Adhesion; D024202:Electrophoretic Mobility Shift Assay; D004797:Enzyme-Linked Immunosorbent Assay; D005434:Flow Cytometry; D015151:Immunoblotting; D016328:NF-kappa B / Q000378:metabolism*; D010006:Osteoblasts / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D010019:Osteomyelitis / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D013203:Staphylococcal Infections / Q000378:metabolism* / Q000473:pathology; D013211:Staphylococcus aureus / Q000166:cytology / Q000378:metabolism*
D016328:NF-kappa B